Medicines and Healthcare Products Regulatory Agency
(asked on 9th January 2023) - View Source
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, how much and what proportion of the Medicines and Healthcare products Regulatory Agency's budget was derived from the public purse in each of the last five financial years.
The information requested is not collected centrally. The Medicines and Healthcare products Regulatory Agency (MHRA) is an executive agency of the Department. The MHRA is primarily funded by income from fees for sales of products and regulatory services. The MHRA’s fees are set to cover full costs incurred by the Agency, in accordance with HM Treasury’s Managing Public Money guidelines. An approximate breakdown of the agency’s funding is 50% fees for services, 25% industry periodic fees and 25% Department funding.
The following table shows the Department’s funding over the previous five financial years.
Financial year | Total |
2021/22 | £29,957,000 |
2020/21 | £43,336,000 |
2019/20 | £43,450,000 |
2018/19 | £34,559,000 |
2017/18 | £28,800,000 |
A more in-depth breakdown of the MHRA’s income and expenditure is available at the following link: